Showing results (61-70 of 120) with videos related to

Sort By:
Pageof 12
The Lancet. Oncology|September 5, 2020
Molecular profiling of neuroendocrine tumours to predict response and toxicity to peptide receptor radionuclide therapyLisa Bodei, Heiko Schöder, Richard P Baum, et al.
Cancers|November 27, 2025
Emerging Diagnostics and Therapies in Neuroendocrine Neoplasms: A Critical ReviewJorge H Hernandez-Felix, Monica Isabel Meneses-Medina, Rachel Riechelmann, et al.
Current Opinion in Endocrinology, Diabetes, and Obesity|July 5, 2012
A rationale for multidisciplinary care in treating neuroendocrine tumoursDavid C Metz, Junsung Choi, Jonathan Strosberg, et al.
World Journal of Gastroenterology|April 25, 2013
United States-based practice patterns and resource utilization in advanced neuroendocrine tumor treatmentJonathan Strosberg, Roman Casciano, Lee Stern, et al.
Pancreas|June 18, 2013
Cytoplasmic Clusterin expression correlates with pancreatic neuroendocrine tumor size and pathological stageEvita B Henderson-Jackson, Aejaz Nasir, Dung-Tsa Chen, et al.
Pancreas|November 6, 2019
FGD4 (Frabin) Overexpression in Pancreatic Neuroendocrine NeoplasmsMohammad Shahid, Tarra B George, James Saller, et al.
Pancreas|February 6, 2018
Long-term Outcomes of Gastroenteropancreatic Neuroendocrine TumorsWeiwei Chi, Richard R P Warner, David L Chan, et al.
Pancreas|May 3, 2021
Comparison of Nausea and Vomiting Associated With Amino Acid Formulations Coinfused With Peptide Receptor Radionuclide Therapy: Commercial Parenteral Nutrition Formulas Versus Compounded Arginine/LysineTaymeyah Al-Toubah, Dhiraj Sikaria, Jose Jesurajan, et al.
Pancreas|January 30, 2013
International practice patterns and resource utilization in the treatment of neuroendocrine tumorsRoman Casciano, Xufang Wang, Lee Stern, et al.
Anticancer Research|August 27, 2011
Palladin is a marker of liver metastasis in primary pancreatic endocrine carcinomasEvita B Henderson-Jackson, James Helm, Jonathan Strosberg, et al.
Pageof 12